NASDAQ
GNLX
Last Price
US $2.63
Valuation
Financial
Performance
Cash flow to debt coverage
Genelux Corporation cash flow to debt ratio of -1.50K% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.
Free cash flow growth
Genelux Corporation's free cash flow has decreased 22.01% from $-21.61M last year to $-26.37M, signaling decreasing performance
Debt-to-equity ratio
Genelux Corporation's debt to equity ratio is 0.11, which means that the company's assets are healthy financed, signaling financial stability.
Debt-to-equity trend
Genelux Corporation's debt has increased relative to shareholder equity from 0.07 last year to 0.11 today, signaling weakened financials
Net debt to EBITDA
Genelux Corporation has a net cash position, so leverage is healthy.
Interest coverage
Genelux Corporation earns at least as much interest as it pays. Interest obligations are fully covered.
Profit margin growth
Genelux Corporation's profit margin has decreased (6.39%) in the last year from -373.36K% to -397.23K%, signaling decreasing performance
Current ratio
Genelux Corporation's short-term assets of $15.13M exceed its short-term liabilities of $6.22M
Return on assets
Genelux Corporation's return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization
Return on equity
Genelux Corporation's return on equity of -165.18%, is lower than 15.00%, indicating bad performance
Earnings quality
Genelux Corporation's operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation
Earnings stability
Genelux Corporation has insufficient public price history to evaluate earnings stability.
Positive free cash flow
Genelux Corporation has negative free cash flow, indicating the company is burning cash rather than generating it
Free cash flow yield
Genelux Corporation has negative free cash flow, indicating cash burn
Earnings growth
Genelux Corporation's yearly earnings has decreased 7.62% since last year from $-29.87M to $-32.15M, signaling decreasing performance
Revenue growth
Genelux Corporation's yearly revenue has increased 0.00% since last year from $8.00K to $8.00K, signaling increasing performance
Return on invested capital
ROIC -132.84% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.
3-year revenue CAGR
Genelux Corporation's 3-year revenue CAGR of -91.03% is negative, indicating declining revenue over the past 3 years
Revenue consistency
Genelux Corporation has insufficient public price history to evaluate revenue consistency.
Return on equity consistency
Genelux Corporation has insufficient public price history to evaluate ROE consistency.
Cash Flow Valuation (DCF)
Genelux Corporation has insufficient data to evaluate this check.
Earnings yield (TTM)
Genelux Corporation has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
EBITDA Valuation
Genelux Corporation is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model
EV/EBITDA (FY)
Genelux Corporation has negative or missing EBITDA, making EV/EBITDA ratio unreliable
PEG ratio (TTM/FY)
Genelux Corporation has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Price-to-book ratio (FY)
Genelux Corporation has a price-to-book ratio of 3.86x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value
Price-to-sales ratio (TTM)
Genelux Corporation has a price-to-sales ratio of 999.00x, which exceeds the 8.00x threshold, indicating the stock may be overvalued relative to its revenue
Profit margin
Current Ratio
Capital Returns
-195.42%
Return on equity
ROIC: -140.13%
Valuation History
-
Price to Earnings
EV/EBITDA: -4.5X
Cash flow
Profit margin
-17.92%
Cash flow
-22.81%
Fair Value
Market $2.63
—
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.